Status:
UNKNOWN
Comparison of Duloxetine Versus Pregabalin
Lead Sponsor:
National Cancer Institute, Egypt
Conditions:
Drug Effect
Eligibility:
FEMALE
18-70 years
Phase:
PHASE2
Brief Summary
Chronic post mastectomy pain syndrome (PMPS) is a chronic post-surgical neuropathic pain following breast cancer surgeries and lasting more than three months after surgeries. Pregabalin is originally ...
Detailed Description
Patients with of 3 months of chronic neuropathic pain after breast surgery (either modified radical mastectomy or conservative breast surgery) combined with axillary dissection is considered as post m...
Eligibility Criteria
Inclusion
- Female, history of breast surgery and patients with post mastectomy pain
Exclusion
- pregnancy,history of allergy to Pregabalin or duloxetine, pregnancy or lactation, history of pregabalin or gabapentin intake in the preceding three months, history of radiotherapy and history of drug abuse
Key Trial Info
Start Date :
December 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2021
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT04727502
Start Date
December 20 2020
End Date
April 1 2021
Last Update
January 27 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nataional Cancer Instituite
Cairo, Egypt